Declaration of Park Lanterman (Mylan Pharmaceuticals, PTAB IPR2017-01526, 17-cv-3140, 150-5)

Date July 13, 2018
Description
Download File Expert-Declaration-of-Mark-Lanterman-2019-07-12-MYLAN-USPTO-PTAB-17-cv-3140.pdf
Relevant Link
Related Case Mylan Pharmaceuticals v. Sanofi-Aventis Deutschland GmbH
To top